Get started
Author

Marina Dyakova

Observed names: Dr. Marina Dyakova, Dyakova, M.E., M. Dyakova, M. E. DYAKOVА, M. E. Dyakova, M. E. Dyakovа, M. Ye. Dyakova, M.E. Dyakova, Marina E. Dyakova, Marina E Dyakova, Marina E. .Dyakova, Marina E. Dyakova
Observed institutions: St Petersburg University, First Pavlov State Medical University of St. Petersburg, Russian Medical Academy of Continuous Professional Education, Institute of Oncology NN Petrov, Ministry of Health of the Russian Federation, Saint-Petersburg Research Institute of Phthisiopulmonology, North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg State Pediatric Medical University
ORCID: 0000-0002-7810-880X
Observed ORCID: 0000-0002-7810-880X
OpenAlex ID: A5113358186
Mesenchymal stem cells-derived extracellular vesicles for therapeutics of renal tuberculosis
2024 · Natalia Yudintceva, Danila Bobkov, et al. · Scientific Reports · 20
The Use of Mesenchymal Stem Cells in the Complex Treatment of Kidney Tuberculosis (Experimental Study)
2022 · Alexander N. Muraviov, Tatiana I. Vinogradova, et al. · Biomedicines · 18
PDF
The system of matrix metalloproteinases and their role in patients with pulmonary tuberculosis
2016 · D.S. Esmedlyaeva, N.P. Alexeyeva, et al. · Biomeditsinskaya Khimiya · 8
PDF
Comparison of Autografts and Biodegradable 3D-Printed Composite Scaffolds with Osteoconductive Properties for Tissue Regeneration in Bone Tuberculosis
2023 · Tatiana I. Vinogradova, Mikhail S. Serdobintsev, et al. · Biomedicines · 7
PDF
Original experimental model of tuberculosis and lung cancer
2022 · Grigorii G. Kudriashov, Andrey O. Nefedov, et al. · Pediatrician (St Petersburg) · 7
The informative value of adenosine deaminase isoenzymes testing in the diagnosis of tuberculous pleurisy with the relevance to the age of patients
2020 · M. E. Dyakova, T. L. Perova, et al. · Tuberculosis and lung diseases · 5
PDF
The Predictive Function of Rates of Matrix Metalloproteinases/inhibitors System When Assessing Reparative Changes in the Lung Tissue in Those With Infiltrate Pulmonary Tuberculosis
2018 · D. S ESMEDLYAEVА, N. P. АLEKSEEVА, et al. · Tuberculosis and lung diseases · 5
PDF
Inflammatory activity and markers of extracellular matrix destruction in pulmonary tuberculoma
2020 · D. S. Esmedlyaeva, N. P. Alekseeva, et al. · Bulletin of Siberian Medicine · 4
PDF
Prognostic role of matrix metalloproteinase system / inhibitors in assessing the nature of reparative changes in infiltrative pulmonary tuberculosis (ITL).
2018 · Diljara Esmedlyaeva, Pavel Gavrilov, et al. · European Respiratory Journal · 4
Long-term chemotherapy of C57BL/6 mice infected with epidemiologically important Mycobacterium tuberculosis strains and molecular insight into host-pathogen interplay
2025 · Tatiana Vinogradova, Natalia Zabolotnykh, et al. · Microbial Pathogenesis · 3
The Effect of Antitumor Drugs on the Course of Tuberculosis in the Experiment
2023 · G.G. Kudriashov, T.I. Vinogradova, et al. · Molekulyarnaya Meditsina (Molecular medicine) · 3
Matrix Metalloproteinases in Pathogenesis of Ventilation Disorders of the Respiratory System in Patients with Chronic Pulmonary Tuberculosis
2022 · D. S. Esmedlyaeva, N. P. Alekseeva, et al. · Tuberculosis and lung diseases · 3
PDF
Nitric Oxide – Biochemical Marker of Tuberculosis Pathogenesis
2017 · M. E. Dyakovа, N. P. Аlekseevа, et al. · Tuberculosis and lung diseases · 3
PDF
Role of Purine Metabolism Enzymes in Immune Pathogenesis of Fibro-cavernous Pulmonary Tuberculosis
2016 · M. Ye. Dyakova, V. Yu. Zhuravlev, et al. · Medical Immunology (Russia) · 3
PDF
Mycobacterium Tuberculosis Biological Properties and Characteristics of the Inflammatory Reaction in Patients With Infiltrative Pulmonary Tuberculosis
2014 · O. T. Titarenko, M. E. Dyakova, et al. · Russian Journal of Infection and Immunity · 3
PDF
Matrix metalloproteinaze inchibitors system and experimental drug-resistant kidney tuberculosis treatment effectiveness
2023 · Dilyara S. Esmedlyaeva, Nina P. Alekseeva, et al. · Pediatrician (St Petersburg) · 2
PDF
Bactericidal Activity of Leukocytes in Pulmonary Tuberculosis Patients
2017 · M. E. Dyakova, D. S. Esmedlyaeva, et al. · Tuberculosis and lung diseases · 2
PDF
Peculiarities of the circulating phagocytes functional activityin patients with different forms of drug-resistant pulmonary tuberculosis
2012 · O.T. Titarenko, M.E. Dyakova, et al. · Biomeditsinskaya Khimiya · 2
PDF
Insight into blood proteinase-inhibitor system and pathogenesis of renal tuberculosis induced by phylogenomically different Mycobacterium tuberculosis strains in rabbit model
2025 · Dilyara Esmedlyaeva, Igor Mokrousov, et al. · BMC Nephrology · 1
PDF
System proteinase/inhibitors in the pathogenesis of experimental kidney tuberculosis
2024 · Dilyara S. Esmedlyaeva, Nina P. Alekseeva, et al. · Kazan medical journal · 1
Enzymes of purine metabolism — biomarkers for the diagnostics of tuberculous pleurisy in patients with HIV infection
2023 · M. E. Dyakova, K. B. Vladimirov, et al. · HIV Infection and Immunosuppressive Disorders · 1
PDF
Markers of Inflammatory Response in Patients With Drug Resistance of Mycobacterium Tuberculosis
2017 · E. N. Belyaeva, M. E. Dyakova, et al. · Journal Infectology · 1
PDF
System of Matrix Metalloproteinases in the Evaluation of Lung Tissue Destruction in Tuberculosis
2015 · D. S. Esmedlyaeva, O. T. Titarenko, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 1
The dependence of the inflammatory reaction on the properties of mycobacterium tuberculosis and the course of specific pulmonary process
2013 · O.T. Titarenko, M.E. Dyakova, et al. · Biomeditsinskaya Khimiya · 1
PDF
Peculiarities of functional activity of circulating phagocytes in patients with different forms of drug-resistant pulmonary tuberculosis
2011 · O. T. Titarenko, M. E. Dyakova, et al. · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · 1
Works count: 58
Citation count: 109
H-index: 5
I10-index: 2
Year
Topic
Type